Open Access

RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma

  • Authors:
    • Jing Yan
    • Zheng‑Hui Wang
    • Yan Yan
    • Hua‑Nan Luo
    • Xiao‑Yong Ren
    • Na Li
    • Guo‑Xi Zheng
    • Jin Hou
  • View Affiliations

  • Published online on: September 10, 2020     https://doi.org/10.3892/or.2020.7762
  • Pages: 2080-2092
  • Copyright: © Yan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Emerging studies have demonstrated that long non‑coding RNAs (lncRNAs) play essential roles in tumorigenesis. However, the role and function of lncRNAs in hypopharyngeal squamous cell carcinoma (HSCC) have not been completely elucidated. The present study explored the function of a novel lncRNA, RP11‑156L14.1, in HSCC. RP11‑156L14.1 was revealed to be highly expressed in HSCC tissues and cell lines. Knockdown of RP11‑156L14.1 inhibited proliferation, migration, and invasion in HSCC cells. Furthermore, RP11‑156L14.1 regulated epithelial‑mesenchymal transition (EMT) by controlling EMT‑related protein expression. Mechanistically, RP11‑156L14.1 exerted its function as a competing endogenous RNA (ceRNA) and directly interacted with miR‑548ao‑3p. The present study also demonstrated that miR‑548ao‑3p regulated signal sequence receptor subunit 1 (SSR1) expression by targeting SSR1 3'‑UTR. Moreover, the xenograft HSCC tumor model revealed that knockdown of RP11‑156L14.1 markedly suppressed HSCC tumor growth in vivo. In summary, these findings indicated that the lncRNA RP11‑156L14.1 functions as an oncogene in HSCC by competing with miR‑548ao‑3p in regulating SSR1 expression. The RP11‑156L14.1/miR‑548ao‑3p/SSR1 axis could be utilized as a potential novel biomarker and therapeutic target for HSCC.
View Figures
View References

Related Articles

Journal Cover

November-2020
Volume 44 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Yan J, Wang ZH, Yan Y, Luo HN, Ren XY, Li N, Zheng GX and Hou J: RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma. Oncol Rep 44: 2080-2092, 2020
APA
Yan, J., Wang, Z., Yan, Y., Luo, H., Ren, X., Li, N. ... Hou, J. (2020). RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma. Oncology Reports, 44, 2080-2092. https://doi.org/10.3892/or.2020.7762
MLA
Yan, J., Wang, Z., Yan, Y., Luo, H., Ren, X., Li, N., Zheng, G., Hou, J."RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma". Oncology Reports 44.5 (2020): 2080-2092.
Chicago
Yan, J., Wang, Z., Yan, Y., Luo, H., Ren, X., Li, N., Zheng, G., Hou, J."RP11‑156L14.1 regulates SSR1 expression by competitively binding to miR‑548ao‑3p in hypopharyngeal squamous cell carcinoma". Oncology Reports 44, no. 5 (2020): 2080-2092. https://doi.org/10.3892/or.2020.7762